Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategy

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2141|168|5|689-700

ISSN: 0007-1048

Source: BRITISH JOURNAL OF HAEMATOLOGY, Vol.168, Iss.5, 2015-03, pp. : 689-700

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract